Skip to content

Obstructive Sleep Apnea in Obese Children and Teenagers - Occurrence and Importance of Intervention

Obstructive Sleep Apnea in Obese Children and Teenagers - Occurrence and Importance of Intervention

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02463201
Enrollment
236
Registered
2015-06-04
Start date
2015-04-30
Completion date
2018-06-30
Last updated
2018-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Obesity, Sleep Apnea, Obstructive

Keywords

Sleep Apnea, Obstructive, Pediatric Obesity

Brief summary

The prevalence of childhood obesity has increased at an alarming rate over the last decades, both globally and in Denmark. There are a number of serious sequelae related to obesity, such as hypertension, hypercholesterolemia, fatty liver and prediabetes. Obesity is found to be a risk factor for obstructive sleep apnea (OSA). OSA in childhood is known to be associated with cardiovascular complications, neurocognitive problems and reduced quality of life. The correlation between obesity and OSA is still poorly understood. Early detection and intervention is of great importance as the health consequences related to OSA as well as obesity are severe. Adenotonsillectomy is recommended as first-line therapy in children with OSA. However, only around 25% of obese children benefit from this treatment compared to around 75% of normal-weight children suggesting that there might be other structural factors predisposing to OSA in obese children. In this study the investigators aim to clarify the impact of obesity in the development of OSA. The prevalence of OSA in obese children will be investigated. Furthermore the purpose is to assess the effect of weight loss on OSA.

Interventions

BEHAVIORALWeight loss

Sponsors

Holbaek Sygehus
CollaboratorOTHER
Zealand University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age: 7-18 years * BMI \> 90th percentile for age and gender

Exclusion criteria

* Neuromuscular disorders * Craniofacial syndromes / malformations * Laryngeal and tracheal malformations

Design outcomes

Primary

MeasureTime frameDescription
Change in obstructive sleep apnea (OSA)One yearOSA will be diagnosed by cardiorespiratory measurement. The examination will be repeated after weight loss.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026